Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
Title:
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
Author:
Kande Betu Ku Mesu, Victor Mutombo Kalonji, Wilfried Bardonneau, Clélia Valverde Mordt, Olaf Ngolo Tete, Digas Blesson, Séverine Simon, François Delhomme, Sophie Bernhard, Sonja Mahenzi Mbembo, Hélène Mpia Moke, Christian Lumeya Vuvu, Steven Mudji E'kitiak, Junior Akwaso Masa, Felix Mukendi Ilunga, Melchias Mpoyi Muamba Nzambi, Dieudonné Mayala Malu, Tim Kapongo Tshilumbwa, Serge Botalema Bolengi, Franck Nkieri Matsho, Mathieu Lumbala, Crispin Scherrer, Bruno Strub-Wourgaft, Nathalie Tarral, Antoine
Appeared in:
The Lancet global health
Paging:
Volume 9 () nr. 7 pages e999-e1008
Year:
2021
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license